Skip to main content
Log in

The Importance of Specific IgG and IgE Autoantibodies to Retinal S Antigen, Total Serum IgE, and sCD23 Levels in Autoimmune and Infectious Uveitis

  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Autoimmunity plays an important role in the development of uveitis. The uveitis are linked to Th1 or Th2 lymphocyte activation. We studied 41 patients with uveitis, divided into autoimmune uveitis (n = 32) and infectious uveitis (n = 9), 30 normal controls, and 20 asthmatic atopic without ocular diseases. The infectious uveitis patients were separated into bacterial (n = 6) and toxoplasmic (n = 3) retinochoroiditis. We measured IgE and sCD23 serum levels and specific IgG and IgE to retinal S antigen by ELISA tests. The IgE levels were 500 ± 325 kU/L in autoimmune uveitis, 57 ± 35 kU/L in bacterial uveitis, 280 ± 38 kU/L in toxoplasmic retinochoroiditis, 75 ± 32 kU/L in the controls, and 557 ± 243 kU/L in atopics (P < 0.0005). The sCD23 levels were 10.4 ± 5.4 ng/ml in autoimmune uveitis, 3.7 ± 1.17 ng/ml in bacterial uveitis, 6.76 ± 1.36 ng/ml in toxoplasmic retinochoroiditis, 3.4 ± 1 ng/ml in controls, and 8.35 ± 2.2 ng/ml in atopic patients (P < 0.005). The specific IgG to retinal S antigen was positive in 27 of 32 cases, and the specific IgE to retinal S antigen was positive in 22 of 32 autoimmune uveitis. The bacterial uveitis patients as well as the controls were negative for both autoantibodies to retinal S antigen. The toxoplasmic retinochoroiditis patients presented specific IgG and IgE to retinal S antigen in two of three cases, respectively, one of them with overlap of both antibodies. These results suggest the importance of specific IgG and IgE to retinal S antigen in autoimmune uveitis, which, along with higher IgE and sCD23 levels, reveal Th2 activation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Palestine AG: Autoimmune uveitis. In Current Therapy in Allergy, Immunology, Rheumatology, LM Lichtenstein, AS Fauci (eds). Toronto/St. Louis, Decker-Mosby, 1985/1986, pp 204-206

    Google Scholar 

  2. Nussenblatt RB, Palestine AG: Concepts of disease pathogenesis. In Uveitis, Fundamentals and Clinical Practice, 1st ed. Chicago, Year Book Medical, 1989, pp 21-52

    Google Scholar 

  3. Friedlander M: Ocular Allergy: In Allergy Principles and Practice, E Middleton, ChE Reed, EF Ellis, NF Adkinson, JW Yunginger, WW Busse (eds). St. Louis, Mosby, 1993, pp 1649-1660

    Google Scholar 

  4. Irani AM: Ocular mast cells and mediators. Immunol Allergy Clin North Am 17:1-18, 1997

    Google Scholar 

  5. Wacker WB, Donoso LA, Kaslow CM, Yankeelov JA, Organiciak DT: Experimental autoimmune uveitis. Isolation, characterization and localization of a soluble uveitopathogenic antigen from bovine retina. J Immunol 119:1949-1958, 1977

    Google Scholar 

  6. Donoso LA, Gregerson DS, Smith L, Robertson S, Knospe V, Vrabed T, Kaslow CM: S antigen: Preparation and characterization of site specific monoclonal antibodies. Curr Eye Res 9:343-355, 1990

    Google Scholar 

  7. Nussenblatt RB, Whitcup SM, Palestine AG: Elements of the immune system, concepts of disease pathogenesis. In: Uveitis. Fundamentals and Clinical Practice, 2nd ed. St. Louis, Mosby, 1996, pp 3-47

    Google Scholar 

  8. Roit IM: The T cell priming hurdle in autoimmune disease and tumor immunity. Immunologist 2:42-46, 1994

    Google Scholar 

  9. Romagnani S, Del Prete GF, Maggi E, Ricci MT: Th1 and Th2 cells and their role in disease. ACI News 5:19-22, 1993

    Google Scholar 

  10. Maliszewski CR, Park LS: The interleukin-4 receptor: Potential therapeutic applications in the allergic response. ACI News 2:86-90, 1990

    Google Scholar 

  11. Kelso A: Th1 and Th2 subsets: paradigms lost? Immunol Today 16:374-379, 1995

    Google Scholar 

  12. Celis E: T Helper cells and autoantibodies in autoimmune disease. Immunologist 1:126-130, 1993

    Google Scholar 

  13. Muraille E, Leo O: Revisting the Th1/Th2 paradigm. Scand J Immunol 47:1-9, 1998

    Google Scholar 

  14. Adorini L, Trembleau S: Autoimmune diabetes as a test for Th1/Th2 paradigm. Immunologist 6:146-150, 1998

    Google Scholar 

  15. Gordon J: CD 23 novel disease marker with a split personality. Clin Exp Immunol 86:356-359, 1991

    Google Scholar 

  16. Gordon J, Katira A, Flores Romo L, Jhonson GD: Membrane CD 23 a target for feedback regulation on IgE synthesis. Inmunología 11:37-43, 1992

    Google Scholar 

  17. Bansal A, Haeny MR, Cochrane S, Pumphrey RSH, Green LM, Bhavnani M, Wilson PB: Serum soluble CD23 in patients with hypogammaglobulinemia. Clin Exp Immunol 97:239-241, 1994

    Google Scholar 

  18. Gordon J: B cell signaling via the C-type lectins CD 23 and CD72. Immunol Today 15:411-417, 1994

    Google Scholar 

  19. Mudde GC, Hansel TT, Reijsen FC, Osterhoff BF, Bruijnzeel Koomen CAFM: IgE: An immunoglobulin specialized in antigen capture? Immunol Today 11:440-443, 1990

    Google Scholar 

  20. Bonnefoy JY, Zyrber Ch P, Henchoz SL, Gauchat JF, Aubry JP, Graber P: A new role for CD23 in inflammation. Immunol Today 17:418-420, 1996

    Google Scholar 

  21. Bansal A, Roberts T, Hay EM, Kay R, Pumphrey RSH, Wilson PB: Soluble CD 23 levels are elevated in the serum of patients with primary Sjögren syndrome and systemic lupus erythematosus. Clin Exp Immunol 89:452-455, 1992

    Google Scholar 

  22. Muiño JC, Kahn A, Wolff EG, Castro CC, Gagliardi JR, Ferrero M, Romero M: The highs CD23 and IgE serum levels in sera of the SLE patients. J Allergy Clin Immunol 101(1,part 2):S121, 1998

    Google Scholar 

  23. Muiño JC, Castro CC, Gagliardi JR, Wolff EG, Gómez RM, Guglielmone H, Alé AM, Ferrero M, Romero MD: Regulación de la respuesta inflamatoria de la aspergilosis alérgica broncopulmonar por antígenos Clase III del complejo mayor de histocompatibilidad (C4, C2, FB), CD 23 soluble y fallas de la fagocitosis. Rev Med Córdoba 85:2-12, 1997

    Google Scholar 

  24. Dorey O, Cozette J, Faure JO: A simple and rapid method for isolation of retinal S antigen. Ophthalm Rev 14:249-255, 1982

    Google Scholar 

  25. Nieto A, Carbonetto CA: Enzimoinmuno-ensayo. In Inmunología e Inmunoquímica, Margni RA (ed). Buenos Aires, Panamericana, 1989, pp 571-586

    Google Scholar 

  26. Dugas B, Mossalay MD, Damais Ch, Kolb JP: Nitric oxide production by human monocytes: Evidence for role of CD 23. Immunol Today 574-589, 1995

  27. McMenamin PG, Crewe J, Istra A: Resident and infiltrating cells in the rat iris during the early stages of experimental melanin protein induced uveitis. (EMIU). Ocular Immunol Inflam 5:223-233, 1997

    Google Scholar 

  28. Chateris DG, Lightman SL: In vivo lymphokine production in experimental uveoretinitis. Immunology 78:387-392, 1993

    Google Scholar 

  29. Liversidge J, Dick A, Cheng YF, Scott GB, Forester JV: Retinal antigen specific lymphoccytes, TCR gamma-delta T cells and CD5+ B cell cultures from vitreous in acute sympathic ophtalmitis. Autoimmunity 15:2257-2266, 1993

    Google Scholar 

  30. Keegan AD, Ryan JJ, Paul WE: IL 4 regulates growth and differentiation by distinct mechanisms. Immunologist 4:194-198, 1996

    Google Scholar 

  31. Lane P, Flynn S, Walker L, Backer T, Gulbrnason-Judge A: CD4 cytokine differentiation. Who or what decides. Immunologist 6:182-185, 1998

    Google Scholar 

  32. Kauffmann SHE: Immunity to intracellular bacterias and protozoa. Immunologist 3:221-225, 1995

    Google Scholar 

  33. Freij BJ, Wiedbrauk DL, Sever JL: Immunologist assessment of infectious diseases. Immunol Allergy Clin North Am 14:451-474, 1994

    Google Scholar 

  34. Thorsby E: HLA associated disease susceptibility. Which genes are primary involved? Immunologist 3:51-58, 1995

    Google Scholar 

  35. Lamont AE, Adorini L: IL 12: A key cytokine in immune regulation. Immunol Today 17:214-217, 1996

    Google Scholar 

  36. Kumar V, Sercarz E, Adorini L: Regulatory mechanisms in organ-specific autoimmunity. Immunologist 6:161-166, 1998

    Google Scholar 

  37. Theofilopoulos AN: The basis of autoimmunity: Part I. Mechanisms of aberrant self-recognition. Immunol Today 16:90-98, 1995

    Google Scholar 

  38. Zinkernagel RM, Kelly J: How antigen influences immunity. Immunologist 5:114-120, 1997

    Google Scholar 

  39. Mitchinson A: Autoimmune disease. Immunologist 5:32-33, 1997

    Google Scholar 

  40. Kruibeek AM: Tolerance. Immunologist 3:176-184, 1995

    Google Scholar 

  41. Stockinger B, Zal T, Volkmann A, Fossati G, Barthlot T: Induction of tolerance or (auto)immunity in MHC class II restricted T cells. Immunologist 6:102-105, 1998

    Google Scholar 

  42. Shinohara N, Komano H, Lee M, Tachibana M, Iwata M: CD4+ T cells, positive selection and surveillance of autoantibody production. Immunologist 5:121-126, 1997

    Google Scholar 

  43. Withcup SM, Nussenblatt RB: Immunologic ocular disease. In Clinical Immunology. Principles and Practice, RR Rich, TA Fleisher, BP Schwartz, WT Shearer, W Strober (eds). St. Louis, Mosby, 1996, pp 1579-1591

    Google Scholar 

  44. Weiner HL, Friedman A, Miller A, Khoury SJ, Sabbagh AA, Santos L, Sayegh M, Nussenblat RB, Trentham DE, Hafler DA: Oral tolerance: Immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of auto-antigens. Annu Rev Immunol 12:809-837, 1994

    Google Scholar 

  45. Röcken M, Racke M, Shevach EM: IL-4 induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease. Immunol Today 17:225-231, 1996

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Muiño, J.C., Juárez, C.P., Luna, J.D. et al. The Importance of Specific IgG and IgE Autoantibodies to Retinal S Antigen, Total Serum IgE, and sCD23 Levels in Autoimmune and Infectious Uveitis. J Clin Immunol 19, 215–222 (1999). https://doi.org/10.1023/A:1020516029883

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1020516029883

Navigation